AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Jasper Therapeutics, Inc.

$0.52 -$1.32 (-71.73%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$0.53
Day Range
$0.51$0.55
Year Range
$0.32$2.42
Market Cap
17.31M
AVG Volume
1.11M
Trailing/Forward PE
-0.33/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-09
Primary Exchange
NASDAQUS
Net Income (USD) · A
-80M-60M-40M-20M0202020212022202320242025
JSPR Net Income (USD) by year
PeriodNet Income (USD)
2025-75.8M
2024-71.27M
2023-64.47M
2022-37.69M
2021-30.64M
2020-31.67M
Operating Income (USD) · A
-100M-75M-50M-25M0202020212022202320242025
JSPR Operating Income (USD) by year
PeriodOperating Income (USD)
2025-83.88M
2024-76.24M
2023-68.86M
2022-51.2M
2021-36.83M
2020-20.68M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: JSPR

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 9 Nov 2026.

Jasper Therapeutics, Inc.
JSPR
Stockpicker

Video analysis: JSPR

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: JSPR

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.